ORCID as entered in ROS

Select Publications
2025, 'PCSK9 deficiency promotes the development of peripheral neuropathy.', JCI insight, pp. e183786, http://dx.doi.org/10.1172/jci.insight.183786
,2025, 'Apolipoprotein E Plasma Concentrations Are Predictive of Recurrent Strokes: Insights From the SPARCL Trial.', Journal of the American Heart Association, 14, pp. e036630, http://dx.doi.org/10.1161/JAHA.124.036630
,2023, 'PCSK9 and the nervous system: a no-brainer?', Journal of lipid research, 64, pp. 100426, http://dx.doi.org/10.1016/j.jlr.2023.100426
,2022, 'A Novel, Orally Bioavailable, Small-Molecule Inhibitor of PCSK9 With Significant Cholesterol-Lowering Properties In Vivo', Journal of Lipid Research, 63, http://dx.doi.org/10.1016/J.JLR.2022.100293
,2022, 'Development of a neuropathy model in pre-diabetic mice', Atherosclerosis, 355, pp. 127 - 128, http://dx.doi.org/10.1016/j.atherosclerosis.2022.06.596
,2022, 'Impact of dyslipidemia on peripheral neuropathy', Atherosclerosis, 355, pp. 31 - 32, http://dx.doi.org/10.1016/j.atherosclerosis.2022.06.178
,2021, 'A Systematic Approach to Assess the Activity and Classification of PCSK9 Variants.', International journal of molecular sciences, 22, http://dx.doi.org/10.3390/ijms222413602
,2021, 'Heart to heart with PCSK9.', European heart journal, 42, pp. 3091 - 3093, http://dx.doi.org/10.1093/eurheartj/ehab480
,